Table 2 Reporting quality assessment of information regarding patients and adverse events
Patient’s information | AEs information | |||||||
|---|---|---|---|---|---|---|---|---|
Study ID (author, year) | Age (gender) | Reason for AT | Patient medical history | Duration from last AT and onset of symptom | Diagnostic test | Clinical outcome (follow up) | Explanation on the association between needling site and lesion | Consideration for other risk factors for AEs |
Bahn (1999) [34] | 45 (M) | WD | WD | WD | WD | WD | WD | ND |
Chun (2014) [19] | 48 (F) | ND | DS | WD | WD | WD | WD | ND |
Chung (2008) [16] | 66 (M) | WD | DS | WD | WD | WD | DS | ND |
Chung (2016) [40] | 62 (M) | WD | DS | WD | WD | WD | DS | ND |
Chung (2020) [33] | 55 (M) | WD | WD | WD | WD | WD | ND | ND |
Ha (2009) [17] | 36 (M) | ND | WD | WD | WD | WD | DS | ND |
Her (2013) [14] | 62 (M) | WD | WD | WD | WD | WD | WD | ND |
Hong (2006) [24] | 46 (M) | ND | WD | ND | WD | WD | ND | ND |
Hwang (2008) [26] | 25 (F) | WD | ND | DS | WD | WD | ND | ND |
Jeon (2004) [22] | 56 (F) | WD | WD | WD | WD | WD | DS | ND |
Kang (2013) [30] | 42 (F) | WD | WD | ND | WD | WD | DS | ND |
Koo (2022) [21] | 64 (F) | WD | DS | WD | WD | WD | DS | ND |
Kim (2006) [25] | 66 (M) | WD | WD | DS | WD | WD | DS | DS |
Kim (2009) [27] | 71 (F) | WD | DS | WD | WD | WD | ND | ND |
Kim (2011a) [36] | 78 (M) | WD | WD | WD | WD | WD | WD | ND |
Kim (2011b) [18] | 55 (M) | WD | WD | WD | WD | WD | DS | ND |
Kim (2011c) [37] | 54 (F) | WD | ND | WD | WD | WD | DS | ND |
Lee (2001) [13] | 27 (F) | WD | WD | WD | WD | WD | WD | ND |
Lee (2005) [23] | 75 (F) | WD | WD | DS | WD | WD | DS | ND |
Lee (2008) [35] | 47 (M) | WD | ND | DS | WD | WD | WD | ND |
Lee (2020) [39] | 58 (F) | WD | WD | WD | WD | WD | WD | DS |
Moon (2013a) [29] | 71 (F) | WD | WD | WD | WD | WD | DS | ND |
Moon (2013b) [38] | 55 (M) | ND | WD | DS | WD | WD | DS | ND |
Park (2013) [28] | 69 (M) | DS | DS | WD | WD | WD | DS | ND |
Park (2019) [31] | 47 (M) | WD | WD | WD | WD | WD | DS | ND |
Sung (2016) [15] | 32 (M) | WD | WD | DS | WD | WD | WD | ND |
Woo (2020) [32] | 66 (F) | ND | ND | WD | WD | WD | DS | ND |
Yeo (2021) [20] | 54 (F) | ND | WD | DS | WD | WD | DS | ND |